PHARMA SERVICES ApS

APSDissolved

CVR 35399208Bredgade 91, 5560 AarupVirksomhedsrådgivning og anden rådgivning om driftsledelse· NACE 702200Est. 2013 · 13 years old0 employees

Overview

PHARMA SERVICES ApS is a Danish APS based in Aarup, operating in the Virksomhedsrådgivning og anden rådgivning om driftsledelse sector. Incorporated in 2013, the company reported revenue of DKK 1.6m in its latest annual filing.

Revenue 2014

1.6M DKK

+141% vs 2013

EBITDA margin

182.6 %

+6734% vs 2013

Net profit 2014

2.9M DKK

+9093% vs 2013

Key ratios

See full ratios →

-79.3 %

Very weak

Among the 10% lowest rated companies in the industry

20132014

0.6×

Average

Around the average of companies in the same industry

20132014

>999 %

Very strong

Among the 10% highest rated companies in the industry

20132014

EBITDA — year on year

DKK thousands

Key figures

Annual report 2014

Revenue	1.6M DKK	+141%
EBITDA	2.9M DKK	+6734%
Net profit	2.9M DKK	+9093%
Total assets	0.1M DKK	-85%
Equity	-0M DKK	-152%
Employees	—	—

Financial development

In its most recent annual report (2014), PHARMA SERVICES ApS reported revenue of DKK 1.6m, an increase of 141% on the year before. The figures on this page draw on 2 annual filings covering 2013 to 2014. The bottom line showed a net profit of DKK 2.9m, and the EBITDA margin stood at 182.6%.

At the end of 2014, current assets covered short-term debt 0.6 times.

Financials

Revenue

DKK thousands

EBITDA

DKK thousands

Income statement

DKK thousands

Item	2014	2013
Revenue	1,600	664
Staff expenses	-1,521	-533
EBITDA	2,921	43
Depreciation & amort.	-0	-0
EBIT	2,921	43
Net financials	-0	-0
Profit before tax	2,920	42
Tax	-0	11
Net profit	2,920	32

Get a credit rating – not just the numbers

Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.

See the credit rating

Balance sheet

DKK thousands

Item	2014	2013
Total assets	53	358
Equity	-42	80
Long-term debt	0	0
Short-term debt	94	278
Total debt	94	278

Financial ratios

5-year trend

EBITDA margin

182.6 %

20132014

Equity ratio

-79.3 %

Very weak

Among the 10% lowest rated companies in the industry

20132014

Return on equity

—

20132014

Net profit margin

182.5 %

Very strong

Among the 10% highest rated companies in the industry

20132014

Asset turnover

30.45×

Very strong

Among the 10% highest rated companies in the industry

20132014

Debt / equity

—

20132014

Sector performance

20 of 28 ratios graded

28 financial ratios from the latest filing, each graded against companies in the same industry.

Profitability

Gross marginStrong

Among the 40% highest rated companies in the industry

The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.

Operating marginVery strong

Among the 10% highest rated companies in the industry

EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.

Net profit marginVery strong

Among the 10% highest rated companies in the industry

The profit for the year as a share of revenue — the company's ability to turn revenue into profit.

Return on assets (ROA)Very strong

Among the 10% highest rated companies in the industry

Net profit as a percentage of total assets — the return generated on the capital employed.

Basic earning power (BEP)Very strong

Among the 10% highest rated companies in the industry

EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.

Return on equity (ROE)Not rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Net profit as a percentage of equity — the return the owners earned on their invested capital this year.

Return on net assets (RONA)Not rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.

Capacity ratioNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.

Liquidity

Current ratioAverage

Around the average of companies in the same industry

Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.

Quick ratioAverage

Around the average of companies in the same industry

Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.

Cash ratioVery weak

Among the 10% lowest rated companies in the industry

Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.

Cash conversion ratioWeak

Among the 40% lowest rated companies in the industry

Cash flow relative to profit — the ability to convert reported profits into accessible cash.

Current assets to equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.

Fixed assets to long-term capitalNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.

Debt & solvency

Solidity ratioVery weak

Among the 10% lowest rated companies in the industry

Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.

Debt ratioVery weak

Among the 10% lowest rated companies in the industry

Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.

Income to debtVery strong

Among the 10% highest rated companies in the industry

Profit relative to debt — the ability to create earnings while operating with debt.

EBITDA to debtVery strong

Among the 10% highest rated companies in the industry

EBITDA relative to debt — how much operating earnings are available to service the debt.

Interest coverageVery strong

Among the 10% highest rated companies in the industry

The ability to pay the interest on the company's debt out of its earnings.

Interest rate on debtVery strong

Among the 20% highest rated companies in the industry

Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.

Interest marginVery strong

Among the 10% highest rated companies in the industry

The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.

Debt to equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.

Liabilities to equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.

Efficiency & development

Asset turnoverVery strong

Among the 10% highest rated companies in the industry

Revenue relative to total assets — the ability to generate revenue from the asset base.

Equity to contributed capitalVery weak

Among the 20% lowest rated companies in the industry

Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.

One-year change in equityVery weak

Among the 10% lowest rated companies in the industry

The size of this year's increase or decrease in the company's equity.

One-year change in debtVery strong

Among the 10% highest rated companies in the industry

The size of this year's increase or decrease in the company's debt.

Inventory turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.

Annual reports & filings

Annual report 2014
Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
View PDF
Annual report 2013
Filed via CVR / Virk · Period 2013-07-02 – 2013-12-31
View PDF

People & ownership

Management

Actively employed in the business

Name	Role	Member since

Former (2)


BS Bende Søndergaard Landtved Management	Management	2013 – 2015
AC Anja Claudia Hoffmann Management	Management	2013 – 2015

Board of directors

Non-executive oversight

No data on file.

Shareholders

Active legal owners

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.

One in three Danish companies experiences fraud

Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.

See the fraud module

Related companies

Company hierarchy

No registered parent or subsidiaries

Board network connections

Board members of PHARMA SERVICES ApS also hold positions in 4 other companies.

Person	Role here	Other companies
Bende Søndergaard Landtved	Management	2 companies
Anja Claudia Hoffmann	Management	2 companies

Frequently asked questions

What is the CVR number of PHARMA SERVICES ApS?

PHARMA SERVICES ApS is registered with CVR / Virk under CVR 35399208.

What is the revenue of PHARMA SERVICES ApS?

PHARMA SERVICES ApS reported revenue of DKK 1.6m in 2014.

Where is PHARMA SERVICES ApS headquartered?

PHARMA SERVICES ApS's registered address is Bredgade 91, kl..